Financial statements Leo Pharma
Balance sheet of Leo Pharma
Company age:
Age:
22 y. 10 m. 21 d.
Share capital:
Share capital:
4 000 PLN
Balance sheet data of LEO PHARMA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 5 946 810,22 | 7 087 132,92 | 8 543 039,83 | 11 285 740,73 | 11 072 600,37 |
| A. Fixed assets | 20 408,27 | 22 654,88 | 18 121,43 | 13 587,98 | 9 054,53 |
| B. Current assets | 5 926 401,95 | 7 064 478,04 | 8 524 918,40 | 11 272 152,75 | 11 063 545,84 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 5 946 810,22 | 7 087 132,92 | 8 543 039,83 | 11 285 740,73 | 11 072 600,37 |
| A. Equity | 2 871 594,25 | 3 365 890,24 | 4 222 533,64 | 5 587 487,52 | 6 470 293,51 |
| B. Liabilities and provisions for liabilities | 3 075 215,97 | 3 721 242,68 | 4 320 506,19 | 5 698 253,21 | 4 602 306,86 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 988 830,83 | 2 282 298,51 | 2 633 796,96 | 3 992 390,08 | 2 984 349,93 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.